Home Reimbursed medicines Atazanavir
Atazanavir — maximum prices and reimbursement
The CANAMED catalogue contains 29 medicines with the active substance Atazanavir, from 4 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Atazanavir there are 29 authorised medicines in the CANAMED catalogue, with maximum retail prices between 734.95 and 4795.05 RON, from 4 manufacturers. For 10 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Atazanavir
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| ATAZANAVIR KRKA 300 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | 734.95 RON | not reimbursed | PR |
| ATAZANAVIR VIATRIS 300 mg | MYLAN HUNGARY KFT - UNGARIA | 992.67 RON | 100% · C2 (national programmes) CNAS pays ~992.67 RON; you ~0.00 RON* |
PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | 1131.87 RON | not reimbursed | PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | 1131.87 RON | not reimbursed | PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | 1131.87 RON | not reimbursed | PR |
| ATAZANAVIR TEVA 150 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | 1202.62 RON | 100% · C2 (national programmes) CNAS pays ~1202.62 RON; you ~0.00 RON* |
PR |
| ATAZANAVIR TEVA 150 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | 1202.62 RON | 100% · C2 (national programmes) CNAS pays ~1202.62 RON; you ~0.00 RON* |
PR |
| ATAZANAVIR TEVA 150 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | 1202.62 RON | 100% · C2 (national programmes) CNAS pays ~1202.62 RON; you ~0.00 RON* |
PR |
| ATAZANAVIR KRKA 150 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | 1484.50 RON | 100% · C2 (national programmes) CNAS pays ~1443.14 RON; you ~41.36 RON* |
PR |
| ATAZANAVIR KRKA 200 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | 1546.29 RON | 100% · C2 (national programmes) CNAS pays ~1546.29 RON; you ~0.00 RON* |
PR |
| ATAZANAVIR STADA 300 mg | REMEDICA LTD - CIPRU | 1615.33 RON | 100% · C2 (national programmes) CNAS pays ~1191.20 RON; you ~424.13 RON* |
PR |
| ATAZANAVIR STADA 150 mg | REMEDICA LTD - CIPRU | 1734.03 RON | 100% · C2 (national programmes) CNAS pays ~1443.14 RON; you ~290.89 RON* |
PR |
| ATAZANAVIR STADA 300 mg | REMEDICA LTD - CIPRU | 1896.90 RON | 100% · C2 (national programmes) CNAS pays ~1191.20 RON; you ~705.70 RON* |
PR |
| ATAZANAVIR STADA 300 mg | REMEDICA LTD - CIPRU | 4795.05 RON | 100% · C2 (national programmes) CNAS pays ~3573.61 RON; you ~1221.44 RON* |
PR |
| ATAZANAVIR KRKA 300 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| ATAZANAVIR STADA 150 mg | REMEDICA LTD - CIPRU | — | not reimbursed | PR |
| ATAZANAVIR STADA 150 mg | REMEDICA LTD - CIPRU | — | not reimbursed | PR |
| ATAZANAVIR STADA 300 mg | REMEDICA LTD - CIPRU | — | not reimbursed | PR |
| ATAZANAVIR STADA 300 mg | REMEDICA LTD - CIPRU | — | not reimbursed | PR |
| ATAZANAVIR TEVA 200 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR TEVA 200 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR TEVA 200 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR TEVA 300 mg | PLIVA HRVATSKA D.O.O. (PLIVA CROATIA LTD.) - CROATIA | — | not reimbursed | PR |
| ATAZANAVIR VIATRIS 150 mg | MYLAN HUNGARY KFT - UNGARIA | — | not reimbursed | PR |
| ATAZANAVIR VIATRIS 300 mg | MYLAN HUNGARY KFT - UNGARIA | — | not reimbursed | PR |
| ATAZANAVIR VIATRIS 300 mg | MYLAN HUNGARY KFT - UNGARIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
Live pharmacy prices
Products with Atazanavir in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Apixaban
- Atorvastatin
- Atomoxetin
- Aripiprazol
- Abirateron
- Amoxicillin + acid clavulanic
- Allopurinol
- Amlodipin
- Adalimumab
- Aciclovir
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Atazanavir
-
Is Atazanavir reimbursed?
Yes. For 10 of the catalogue entries with Atazanavir we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Atazanavir?
The maximum retail prices (the CANAMED legal cap) for medicines with Atazanavir are between 734.95 and 4795.05 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Atazanavir is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Atazanavir are in the CANAMED catalogue?
The CANAMED catalogue holds 29 authorised medicines with the active substance Atazanavir — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go